Aaron Sato
Chief Tech/Sci/R&D Officer at TWIST BIOSCIENCE CORPORATION
Profile
Presently, Aaron K. Sato is Chief Scientific Officer for Twist Bioscience Corp. In his past career he was Vice President-Research at Sutro Biopharma, Inc., Chief Scientific Officer of LakePharma, Inc., Vice President-Protein Sciences at Surrozen, Inc., Director-Antibody Engineering at OncoMed Pharmaceuticals, Inc. and Senior Director-Discovery at Dyax Corp. Aaron K. Sato received a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Puget Sound.
Aaron Sato active positions
| Companies | Position | Start |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Former positions of Aaron Sato
| Companies | Position | End |
|---|---|---|
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Chief Tech/Sci/R&D Officer | 2018-05-31 |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2016-12-31 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 2012-06-30 |
| DYAX CORP. | Corporate Officer/Principal | 2006-06-30 |
Training of Aaron Sato
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Puget Sound | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Aaron Sato
